Flex Pharma (FLKS) Tops Q3 EPS by 7c

Flex Pharma (NASDAQ: FLKS) reported Q3 EPS of ($0.65), $0.07 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $586 thousand versus the consensus estimate of $110 thousand.

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

You May Also Be Interested In

• Honeywell (HON) Tops Q1 EPS by 8c, Beats on Revenue; Offers FY Guidance
• Escalade (ESCA) Reports Q1 EPS of $0.13
• STMicroelectronics N.V. (STM) Misses Q1 EPS by 9c; offers Q2 outlook